3 Reasons Not to Sleep on ResMed Stock

Company Overview - ResMed is a leading company in the respiratory care devices sector, producing equipment like CPAP machines that assist millions with sleep apnea and COPD, claiming to have improved over 144 million lives in the past year [2] Growth Performance - ResMed has a market value of nearly $38 billion and has averaged annual stock gains of 15.6% over the past 15 years and 16.9% over the past 10 years, although growth has slowed to an average of 6.5% over the last three years [3] - The company reported a year-over-year revenue increase of 11% in Q2 of fiscal 2026, with gross profit margins and income from operations rising by 18% [4] Strategic Investments - ResMed is focusing on innovation and digital health technologies to enhance growth, with investments in next-generation masks, cloud-connected devices, and digital healthcare software [6][7] - The CEO highlighted the importance of their digital health ecosystem, which spans over 140 countries, in driving demand for their products [5]